Safety Evaluation of Nivolumab Concomitant With Platinum-Based Chemoradiation therapy for Intermediate and High-Risk Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504

Authors :: Robert L. Ferris
A.D. Colevas
John F. Deeken
D.A. Clump
Richard C.K. Jordan
Jonathan Harris
Loren K. Mell
James Ohr
Christina S. Kong
Q.T. Le
Kevin L. Moore
Dukagjin Blakaj
Mitchell Machtay
Q. Zhang
Kai He
C. Kirsch
Walter J. Curran
Maura L. Gillison
Minh Tam Truong
Source :: International Journal of Radiation Oncology*Biology*Physics. 100:1307-1308
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Radiation
business.industry
medicine.disease
Head and neck squamous-cell carcinoma
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Concomitant
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
Nivolumab
030223 otorhinolaryngology
business

Full Text Access

Tools